U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664943) titled 'The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence' on May 19.
Brief Summary: Most patients with glaucoma use eye drops to lower their intraocular pressure. However, poor adherence to prescribed eye drop regimens can lead to significant loss of vision-related quality of life. This study will test the iDrop Device (iD2), a device-on-cap electronic platform monitor designed to accurately track when a research participant removes an eye drop bottle cap, wirelessly communicate usage data to a database accessible to researchers, and send on-demand alerts when a medication is due. A device capable of tracking eye drop usage and ...